Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 0 | 69 | 290 | 2,195 | 60 |
| Cost of Goods | N/A | N/A | 192 | 132 | 105 |
| Gross Profit | N/A | 499 | 98 | 2,063 | -45 |
| Operating Expenses | 1,464 | 298 | 1,023 | 1,222 | 1,155 |
| Operating Income | -1,464 | -229 | -733 | 973 | -1,095 |
| Other Income | -759 | -126 | 0 | 7 | 7 |
| Pre-tax Income | -2,223 | -354 | -733 | 980 | -1,088 |
| Net Income Continuous | -2,223 | -354 | -733 | 980 | -1,088 |
| Net Income Discontinuous | 37 | N/A | N/A | N/A | N/A |
| Net Income | $-2,186 | $-870 | $-733 | $980 | $-1,088 |
| EPS Basic Total Ops | -786.71 | -437.06 | -262.24 | 437.06 | -437.06 |
| EPS Basic Continuous Ops | -786.71 | -199.66 | -278.48 | 394.57 | -440.90 |
| EPS Basic Discontinuous Ops | 12.82 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -786.71 | -437.06 | -262.24 | 437.06 | -437.06 |
| EPS Diluted Continuous Ops | -786.71 | -196.47 | -278.48 | 391.38 | -440.90 |
| EPS Diluted Discontinuous Ops | 12.82 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,384 | $-154 | $-642 | $1,061 | $-1,002 |